Intralipid – myth or miracle?

Intralipid is one of the most exciting recent developments in clinical toxicology (right up there with high-dose insulin euglycemic therapy, aka HIET). We are rightly skeptical of any new therapy, especially one that promises so much. Nevertheless, many of the animal studies and published case reports are quite dramatic.

For instance, this video shows the left ventricular pressure and electrocardiogram tracings of an intact, anesthetized rat during acute bupivacaine cardiotoxicity and successful recovery with a lipid emulsion infusion.

WARNING: you may develop optokinetic nystagmus watching this!

The Poison Review recently commented on the first published case describing the clinical use of intralipid in reversing propanolol toxicity. Importantly, some of the caveats in interpreting this type of report are highlighted. Nevertheless, it’s well worth remembering intralipid as a last-ditch measure for the resuscitation of a patients with cardiotoxicity induced by a lipophilic drug.

You can find out more about intralipid from its major proponents at lipidrescue.org. They suggest the use of intralipid when standard resuscitation methods fail to re-establish sufficient circulatory stability. Their suggested treatment protocol (with my comments in brackets) is as follows:

20% Intralipid

  • 1.5 mL/kg as an initial bolus
    (e.g. about 100 mL in a 70kg adult)
    followed by
  • 0.25 mL/kg/min for 30-60 minutes
    (e.g. about 600 mL over 30 minutes in a 70kg adult)
  • Bolus could be repeated 1-2 times for persistent asystole
    (e.g. at 5 minute intervals)
  • Infusion rate could be increased if blood pressure declines
    (e.g. double the infusion rate)

Most importantly, however, we must remember to do the basics right — maintain effective CPR throughout — and don’t give up! Good neurological outcomes can be achieved even with hours of CPR in the setting of cardiotoxic poisoning.

References

  • Cave G, Harvey M. Intravenous lipid emulsion as antidote beyond local anesthetic toxicity: a systematic review. Acad Emerg Med. 2009 Sep;16(9):815-24. PMID: 19845549.
  • Leskiw U, Weinberg GL. Lipid resuscitation for local anesthetic toxicity: is it really lifesaving? Curr Opin Anaesthesiol. 2009 Oct;22(5):667-71.  PMID: 19581805.
  • Sirianni AJ, Osterhoudt KC, Calello DP, Muller AA, Waterhouse MR, Goodkin MB, Weinberg GL, Henretig FM. Use of lipid emulsion in the resuscitation of a patient with prolonged cardiovascular collapse after overdose of bupropion and lamotrigine. Ann Emerg Med. 2008 Apr;51(4):412-5, 415.e1. Epub 2007 Sep 4. PMID: 17766009.
Print Friendly

Comments

  1. Sarah Silver says

    I should’ve written up case reports. Have had successful case of reversal of cardiac arrest with intralipid therapy: overdose of amitryptyline (roughly 90 tablets of 50 mg preparation). This was a few years ago, maybe 2009? We gave the infusion during the 60 or so minutes of CPR on the patient along with bicarb ggt, usual resuscitation drugs etc. The pateint was discharged to psych on day 3 of hospitalization. Did NOT have success with diphenhydramine overdose (300 tablets of 25 mg preparation) where patient arrived in with grand mal seizure and shortly afterwards went into pulseless vtach. The patient did exit the malignant rhythm, but expired several hours later in the ICU.
    That being said, definately a therapy that we should be pulling out of our pockets for these cases. Today at department meeting, making staff aware of the use of intralipids for overdose with cardiotoxic effects so that we don’t get a lot of head scratching from the RN’s when it is suggested.

Comments